American Kidney Fund, Home Dialyzors United Partner to Host Second Annual Dialysis at Home Summit
September 12, 2023 10:24 ET
|
American Kidney Fund
ROCKVILLE, Md., Sept. 12, 2023 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) has partnered with Home Dialyzors United, a nonprofit advocating on behalf of the home dialyzor community, to host...
Travere Therapeutics Joins American Kidney Fund’s 2023 Corporate Membership Program at ‘Champion’ Level
September 08, 2023 09:51 ET
|
American Kidney Fund
ROCKVILLE, Md., Sept. 08, 2023 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) today announced that Travere Therapeutics has joined the 2023 class in AKF’s Corporate Membership Program as a...
Amgen Joins American Kidney Fund’s 2023 Corporate Membership Program at ‘Champion’ Level
September 06, 2023 09:10 ET
|
American Kidney Fund
ROCKVILLE, Md., Sept. 06, 2023 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) today expressed its appreciation for Amgen’s participation in the 2023 class of its Corporate Membership Program as...
Unicycive Announces Second Quarter 2023 Financial Results and Provides Business Update
August 14, 2023 17:36 ET
|
Unicycive Therapeutics, Inc.
Recent Data Publications Highlight the Benefits of Oxylanthanum Carbonate (OLC) to Improve Medication Adherence and Quality of Life for Patients with Chronic Kidney Disease Feedback from FDA...
Akebia’s Vafseo (vadadustat) Poised to Make Waves for GSK’s Jesduvroq and FibroGen/Astellas’ Evrenzo
July 20, 2023 15:07 ET
|
Spherix Global Insights
Exton, Pennsylvania, July 20, 2023 (GLOBE NEWSWIRE) -- Nephrologists have long awaited the approval of HIF-PH inhibitors for the treatment of anemia in their chronic kidney disease (CKD) patients....
Unicycive Therapeutics to Participate in the H.C. Wainwright 2nd Annual Kidney Conference
July 20, 2023 07:03 ET
|
Unicycive Therapeutics, Inc.
LOS ALTOS, Calif., July 20, 2023 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the...
ZyVersa Therapeutics' CEO, Stephen C. Glover, Is an Invited Speaker at H.C. Wainwright 2nd Annual Kidney Conference to be Held Virtually on July 25, 2023
July 14, 2023 07:37 ET
|
ZyVersa Therapeutics
ZyVersa is advancing a dynamic pipeline of drug candidates with multiple programs built around two proprietary technologies – Cholesterol Efflux Mediator™ VAR 200 for treatment of kidney diseases, and...
American Kidney Fund Announces $250,000 Grant from the Robert I. Schattner Foundation in Support of Pediatric Kidney Disease Programs and Safety Net Grants
July 05, 2023 09:11 ET
|
American Kidney Fund
ROCKVILLE, Md., July 05, 2023 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) is pleased to announce a $250,000 grant from the Robert I. Schattner Foundation, a private charitable foundation...
Healthmap Solutions Names Eli Wahesh as Chief Operating Officer
June 06, 2023 08:00 ET
|
Healthmap Solutions
TAMPA, Fla., June 06, 2023 (GLOBE NEWSWIRE) -- Kidney population health management company Healthmap Solutions (Healthmap) has named Eli Wahesh its new Chief Operating Officer (COO). Filling the COO...
American Kidney Fund Activates Disaster Relief Program to Support Dialysis and Post-Transplant Patients Affected by Typhoon Mawar
May 25, 2023 09:03 ET
|
American Kidney Fund
ROCKVILLE, Md., May 25, 2023 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) has turned on its Disaster Relief Program to administer emergency grants to dialysis and post-transplant patients who...